Skip to main content

Table 2 Design matrix of cefuroxime axetil mucoadhesive minitablets by employing Box–Behnken design

From: Formulation development, optimization and characterization of mucoadhesive minitablets of cefuroxime axetil: in vitro, ex vivo and in vivo pharmacokinetic evaluation

Experimental runs

Factor 1

Factor 2

Factor 3

Response 1

Response 2

Response 3

A: Conc. of chitosan (mg)

B: conc. of HPMC K 100 M (mg)

C: conc. of sodium CMC (mg)

Friability (%)

Drug content (%)

Mucoadhesive strength (%)

1

1

0

− 1

0.22

98.9

6.697

2

1

− 1

0

0.22

95.3

7.256

3

1

1

0

0.22

97.1

7.256

4

0

1

− 1

0.19

97.1

6.697

5

0

0

0

0.19

98.9

7.256

6

0

− 1

− 1

0.19

95.3

6.697

7

− 1

0

− 1

0.16

98.9

6.184

8

0

− 1

1

0.19

95.3

8.674

9

0

1

1

0.19

97.1

8.674

10

1

0

1

0.22

98.9

8.674

11

0

0

0

0.18

98.9

7.256

12

0

0

0

0.19

98.9

7.858

13

− 1

− 1

0

0.16

95.3

8.674

14

− 1

1

0

0.18

99.4

7.256

15

− 1

0

1

0.18

98.9

8.674

  1. − 1: Low level (2 mg), 0: Intermediate (6 mg), + 1: High level (10 mg)